Passage Bio Inc Cash Flow-to-Debt Ratio
Passage Bio Inc cash flow-to-debt ratio. Passage Bio Inc (PASG) has a Cash Flow-to-Debt Ratio of -0.44x as of June 2026, meaning its operating cash flow of $-9.18 Million could theoretically repay 0% of its total liabilities ($20.72 Million) in one year. See financial agility of Passage Bio Inc to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Passage Bio Inc (2018–2025)
Cash flow-to-debt ratio of Passage Bio Inc from 2018 to 2025. Historical debt coverage capacity for Passage Bio Inc across 8 annual periods. Also explore Passage Bio Inc (PASG) net asset momentum to track the company's year-over-year net asset growth rate.
Passage Bio Inc Cash Flow-to-Debt Ratio by Year (2018–2025)
Passage Bio Inc cash flow-to-debt ratio by year from 2018 to 2025. Year-by-year debt coverage analysis for Passage Bio Inc. For the full cash flow conversion analysis, see PASG cash flow metrics.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.72x | $-31.51 Million | $43.53 Million | ▲ +37.9% |
| 2024 | -1.17x | $-47.96 Million | $41.15 Million | ▲ +41.5% |
| 2023 | -1.99x | $-78.26 Million | $39.26 Million | ▲ +28.9% |
| 2022 | -2.80x | $-118.21 Million | $42.18 Million | ▲ +19.6% |
| 2021 | -3.48x | $-126.88 Million | $36.42 Million | ▼ -0.8% |
| 2020 | -3.46x | $-80.52 Million | $23.29 Million | ▲ +63.1% |
| 2019 | -9.36x | $-39.90 Million | $4.26 Million | ▼ -2201.3% |
| 2018 | -0.41x | $-18.57 Million | $45.63 Million | — |